Feed A
A

Agilent Technologies

A · NYSE

$156.29 +1.69% (+$2.60)
1M +1.23%
Market Cap $41.5B
P/E Ratio 28.80x
Div. Yield 0.52%
ROE 20.47%

Bulios Fair Price

$144.24

7.7% downside

Trenutna cena

$156.29

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price je delnica A trenutno precenjena glede na svojo tržno ceno. Kako deluje?

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Piotroski F-Score Moderate
6/9
Valuation
28 /100
Expensive
P/FCF 27.36x
P/E 28.80x
P/B 5.63x
Growth
36 /100
Stable
FCF growth 4.11%
EPS growth 3.02%
Book val. growth 8.31%
Profitability
93 /100
Strong
Op. margin 22.23%
Gross margin 39.60%
FCF margin 20.56%
Quality
74 /100
Excellent
ROA 10.31%
ROIC 11.88%
Asset turnover 0.53x
Debt
88 /100
Low
Int. coverage 26.90x
Debt/Equity 0.54x
Net debt/EBITDA 1.13x
Stability
89 /100
Stable
EPS volatility 2.75%
Beta 1.24x
Profitable years 6

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o A
Online

O podjetju

Agilent Technologies, Inc. is an American technology company specializing in the development and manufacturing of analytical and diagnostic technologies. The company provides a wide range of products and services used in scientific research, industrial analysis, pharmaceutical sector, and diagnostic laboratories. Agilent manufactures laboratory instruments, measurement and analytical instruments, software, and reagents that enable customers to perform precise analyses and testing in various industries. The company is known for the quality of its products, technological leadership, and innovations, which make it a leader in the analytical industry. Agilent Technologies collaborates with research institutions, industrial companies, and healthcare facilities worldwide. Agilent Technologies, Inc. (A) shares are an interesting choice for investors who follow the technology industry and seek investment opportunities in an innovative and established company with a global reach.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

CEO

Padraig McDonnell

Employees

18,100

Headquarters

Santa Clara

Prihajajoči dogodki

23 NOV.

Earnings

Upcoming earnings report

66d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.